A guide to pharma EU risk assessments
They are often inconspicuous, but just as often indispensable: excipients are far more than passive additions to active pharmaceutical ingredients […]
A guide to pharma EU risk assessments Read More »
Integer cursus hendrerit massa, et vulputate tellus efficitur non. Proin tristique augue eget tristique varius.
They are often inconspicuous, but just as often indispensable: excipients are far more than passive additions to active pharmaceutical ingredients […]
A guide to pharma EU risk assessments Read More »
U.S. policy discussions include tariff rates reportedly up to triple digits on certain imported finished drugs. While details are evolving,
U.S. mulls steep tariffs on imported drugs Read More »
The EU Council adopted its negotiating position on the first major overhaul of pharmaceutical legislation since 2004. The package targets
EU “Pharma Package” moves to trilogue Read More »
As the pharmaceutical sector accelerates into a post-pandemic era, the global API market is expected to reach unprecedented levels. Rising
Global API Market Outlook: Opportunities & Challenges for 2025 Read More »
In the current pharmaceutical ecosystem, a delayed delivery or compromised batch can cost millions and damage credibility. This is why
How Supply Chain Reliability is Driving Pharma Success Worldwide Read More »